Activated MEK Suppresses Activation of PKR and Enables Efficient Replication and In Vivo Oncolysis by Δγ 1 34.5 Mutants of Herpes Simplex Virus 1
Open Access
- 1 February 2006
- journal article
- Published by American Society for Microbiology in Journal of Virology
- Vol. 80 (3) , 1110-1120
- https://doi.org/10.1128/jvi.80.3.1110-1120.2006
Abstract
Herpes simplex virus mutants lacking the γ134.5 gene are not destructive to normal tissues but are potent cytolytic agents in human tumor cells in which the activation of double-stranded RNA-dependent protein kinase (PKR) is suppressed. Thus, replication of a Δγ134.5 mutant (R3616) in 12 genetically defined cancer cell lines correlates with suppression of PKR but not with the genotype of RAS. Extensive analyses of two cell lines transduced with either dominant negative MEK (dnMEK) or constitutively active MEK (caMEK) indicated that in R3616 mutant-infected cells dnMEK enabled PKR activation and decreased virus yields, whereas caMEK suppressed PKR and enabled better viral replication and cell destruction in transduced cells in vitro or in mouse xenografts. The results indicate that activated MEK mediates the suppression of PKR and that the status of MEK predicts the ability of Δγ134.5 mutant viruses to replicate in and destroy tumor cells.Keywords
This publication has 57 references indexed in Scilit:
- Ionizing Radiation Activates Late Herpes Simplex Virus 1 Promoters via the p38 Pathway in Tumors Treated with Oncolytic VirusesCancer Research, 2005
- Defects in Translational Regulation Mediated by the α Subunit of Eukaryotic Initiation Factor 2 Inhibit Antiviral Activity and Facilitate the Malignant Transformation of Human FibroblastsMolecular and Cellular Biology, 2004
- Comparison of safety, delivery, and efficacy of two oncolytic herpes viruses (G207 and NV1020) for peritoneal cancerCancer Gene Therapy, 2002
- Mutations of the BRAF gene in human cancerNature, 2002
- Regulation of herpes simplex virus γ134.5 expression and oncolysis of diffuse liver metastases by Myb34.5Journal of Clinical Investigation, 2002
- The use of a genetically engineered herpes simplex virus (R7020) with ionizing radiation for experimental hepatomaGene Therapy, 2002
- Opposing Effects of ERK and JNK-p38 MAP Kinases on ApoptosisScience, 1995
- Characterization of monoclonal antibodies recognizing amino- and carboxy-terminal epitopes of the herpes simplex virus UL42 proteinVirus Research, 1995
- Evidence that wild‐type TP53, and not genes on either chromosome 1 or 11, controls the tumorigenic phenotype of the human fibrosarcoma HT1080Genes, Chromosomes and Cancer, 1994
- Characterization of Herpes Simplex Virus Strains Differing in their Effects on Social Behaviour of Infected CellsJournal of General Virology, 1968